GINKGO BIOWORKS HOLDINGS, INC. Contingent Consideration Classified as Equity, Fair Value Disclosure
GINKGO BIOWORKS HOLDINGS, INC. (DNA) had Contingent Consideration Classified as Equity, Fair Value Disclosure of $800.00 thousand as of 2022-12-31, per its 10-K filed 2023-03-13.
Discontinued › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure · last filed 2023-03-13
- 2022-12-31: Contingent Consideration Classified as Equity, Fair Value Disclosure $800.00K.
- 2022-09-30: Contingent Consideration Classified as Equity, Fair Value Disclosure $800.00K.
| Period end | Contingent Consideration Classified as Equity, Fair Value Disclosure |
|---|---|
| 2022-12-31 | $800.00K 10-K · filed 2023-03-13 |
| 2022-09-30 | $800.00K 10-Q · filed 2022-11-14 |